Hologic Stock Alpha and Beta Analysis

HOLX Stock  USD 79.39  0.63  0.80%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Hologic. It also helps investors analyze the systematic and unsystematic risks associated with investing in Hologic over a specified time horizon. Remember, high Hologic's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Hologic's market risk premium analysis include:
Beta
0.26
Alpha
(0.12)
Risk
1.23
Sharpe Ratio
(0.02)
Expected Return
(0.02)
Please note that although Hologic alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Hologic did 0.12  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Hologic stock's relative risk over its benchmark. Hologic has a beta of 0.26  . As returns on the market increase, Hologic's returns are expected to increase less than the market. However, during the bear market, the loss of holding Hologic is expected to be smaller as well. At this time, Hologic's Book Value Per Share is fairly stable compared to the past year. Tangible Book Value Per Share is likely to rise to 3.75 in 2024, whereas Price Book Value Ratio is likely to drop 3.56 in 2024.

Enterprise Value

1.98 Billion

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Hologic Backtesting, Hologic Valuation, Hologic Correlation, Hologic Hype Analysis, Hologic Volatility, Hologic History and analyze Hologic Performance.
For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.

Hologic Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Hologic market risk premium is the additional return an investor will receive from holding Hologic long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Hologic. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Hologic's performance over market.
α-0.12   β0.26

Hologic expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Hologic's Buy-and-hold return. Our buy-and-hold chart shows how Hologic performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Hologic Market Price Analysis

Market price analysis indicators help investors to evaluate how Hologic stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Hologic shares will generate the highest return on investment. By understating and applying Hologic stock market price indicators, traders can identify Hologic position entry and exit signals to maximize returns.

Hologic Return and Market Media

The median price of Hologic for the period between Wed, Aug 14, 2024 and Tue, Nov 12, 2024 is 80.91 with a coefficient of variation of 1.27. The daily time series for the period is distributed with a sample standard deviation of 1.03, arithmetic mean of 80.93, and mean deviation of 0.82. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Acquisition by Stamoulis Christiana of 90 shares of Hologic at 26.74 subject to Rule 16b-3
08/21/2024
2
Hologic Rises Yet Lags Behind Market Some Facts Worth Knowing
10/08/2024
3
Hologic to acquire Gynesonics
10/14/2024
4
Hologic to lay off 86 people in closure of Connecticut facility
10/23/2024
5
Molten Ventures reports steady performance amid currency challenges
10/30/2024
6
Hologic Reports Q4 Earnings What Key Metrics Have to Say
11/04/2024
7
Earnings call Hologic reports solid Q4 and FY 2024 results, optimistic for 2025
11/05/2024
8
Hologic Given New 89.00 Price Target at Royal Bank of Canada
11/07/2024
9
Implied Volatility Surging for Hologic Stock Options
11/08/2024

About Hologic Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Hologic or other stocks. Alpha measures the amount that position in Hologic has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
 2016 2022 2023 2024 (projected)
Days Sales Outstanding46.3656.6654.3791.23
PTB Ratio3.253.413.743.56

Hologic Upcoming Company Events

As portrayed in its financial statements, the presentation of Hologic's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Hologic's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Hologic's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Hologic. Please utilize our Beneish M Score to check the likelihood of Hologic's management manipulating its earnings.
1st of February 2024
Upcoming Quarterly Report
View
6th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
14th of November 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
30th of September 2023
Last Financial Announcement
View

Build Portfolio with Hologic

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Hologic Stock Analysis

When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.